Notice: Undefined variable: paged in /home/customer/www/salesforcedev.connect.org/public_html/wp-content/themes/Divi-child-theme/companies-shortcode.php on line 382
Wednesday September 23rd, 2020
Breakfast w/ Companies
VC Speaker Sessions
Tuesday September 22nd, 2020
3:30pm — 10pm
— VCs Only —
The Tuesday Demo Day and Ball Game are invite-only events. If you represent a firm and would like to attend, please email firstname.lastname@example.org.
If you are a startup and would like to demo, apply to be a Cool Company.
Aquacyle provides the BioElectricalchemical Treatment Technology (BETT) for onsite wastewater treatment. The BETT systems eliminate up to 80% of incoming primary sludge, recover energy as direct electricity (no methane) and can provide 90% reduction in footprint and a 50-90% reduction in operating expenses relative to conventional aerobic approaches for high-strength wastewater streams.Read More >
Ateios has developed a revolutionary battery technology that will reshape electronics. Primary Zinc Printable Flexible Batteries. The first all printable flexible battery with an areal capacity of 2.5 mAh/cm2. With its proprietary, platform technology based on nanocomposite ink formulation, Ateios’ first all-printed, ultra-thin, flexible battery will enable new form factors that were once unimaginable.Read More >
Bitmo is a mobile gifting platform transforming a $160 billion gift card industry. Its innovative platform allows consumers to gift easily and securely right from their mobile wallet. Unlike plastic gift cards, Bitmo is highly flexible and allows users the ability to split and even exchange card value from one store to another for free. […]Read More >
Cardea is merging the digital and biological domains into a single system, providing for instant, immediate, and complex biochemical analysis in any setting. We do this through our patented graphene biosensor. We partner with other companies to serve multiple markets simultaneously, helping others be competitive in markets as diverse as genomics, drug testing, diagnostics and […]Read More >
A Data-as-a-Service company that provides a proprietary end to end platform for small and medium sized direct-to-consumer companies to truly harness their data for better business decisions.Read More >
GigaIO enables the data center applications of tomorrow: AI/DL, the Industrial Internet of Things, Edge computing, and disaggregation, by solving the #1 compliant: interconnect performance and flexibility. The large variety of new compute and storage technologies makes demands on the interconnects that bind them together that today severely reduce system performance. Legacy interconnects were never […]Read More >
We use technology to improve last mile delivery and moving experiences for our customers. Our mission is to organize the world’s trucks to make them more accessible and useful. Our vision is to create the largest network of trucks in the world. More than 50,000 customers and 6,000 Delivery Professionals trust GoShare to deliver. Download our free app on iPhone/Android or book on our website. 2019 — […]Read More >
GoSite provides a modern tech stack to small businesses that make it easier for their customers to find, book, and pay for their services online.Read More >
Your live hangout where you share your experiences. Watch movies with 100+ friends, play and share games, watch sports, hangout, and more!Read More >
LabFellows provides SaaS workflow automation tool for life sciences operations. We believe scientists developing medical breakthroughs shouldn’t have to spend 42% of their day on lab administrative tasks to meet compliance, logistics, and procurement needs of life science companies. Before LabFellows, they had to. Our platform and proprietary FUSION technology streamlines 17 hours a week […]Read More >
MemComputing delivers quantum computing performance to any computer with our software-based MemCPU(tm) Coprocessors. Developed at UC San Diego by two PhD Physicists.Read More >
NeuraLace Medical is a startup medical device company founded in San Diego whose bold mission is to disrupt the chronic pain epidemic.Read More >
Persephone Biome uses artificial intelligence to rapidly develop microbial based immunotherapies to enable a lifetime without cancer.Read More >
ProciseDx provides point-of-care testing that delivers precise, high-quality results—empowering physicians and patientsRead More >
Seraphina Therapeutics is leveraging the evolution of longevity to help people live longer, healthier lives. By upregulating mechanisms evolved in long-lived species, Seraphina has a generated a rich pipeline of promising therapeutics and novel genetic targets. Seraphina’s therapeutic candidates are being developed to treat comorbidities of aging and to slow the rate of aging itself.Read More >
Shadowbox is a patented technology platform connecting any two or more web applications without requiring application level API integrations. Initially tackling the $300B healthcare interoperability challenge and specifically the diagnostic lab segment, Shadowbox is disrupting the integration market by fundamentally changing the way systems securely, compliantly, and accurately transmit protected patient data.Read More >
Tiled is a microapp platform. A microapp is an informational interactive content experience that is built without code. Tiled microapps enable sales, marketing and HR teams to have more effective conversations and communication.Read More >
The Trials.ai Smart Protocol solution leverages frontier technology to intelligently guide research teams through the process of designing their clinical trials, saving Pharma, Biotech & Device companies time and money.Read More >
Trust & Will
Trust & Will is modernizing the $170B trust and estate planning industry with an easy, fast, and secure way to set up your estate plan online. Our vision is to establish Trust & Will as the category leader for a modern estate planning solution, and our mission is to help everyone leave their legacy.Read More >
Ubiq, the trailblazer in digital data security, has developed a multi-patented, ultra-low latency and low impact solution that secures any type of data, on any device, anywhere, delivering on the promise of a “fast and safe connected world.” Our extremely lightweight, 100% software stack can be directly integrated into existing applications, IoT devices or installed […]Read More >
Vivid Genomics is a precision medicine company dedicated to improving the success of drug development in neurodegenerative disease.Read More >
Voterfied’s participatory democracy platform bridges the communication gap between politicians and constituents by establishing an engagement hub where citizens vote on important issues, using secure blockchain technology to record their opinions. Voterfied educates citizens on the issues, allows them to be heard, encourages informed decision-making by representatives, and decreases political disenfranchisement. As an always-on virtual […]Read More >
WinSanTor Inc. is a clinical-stage biotechnology company focused on the discovery and development of treatments for peripheral neuropathies.Read More >
Yembo is building computer vision and AI technology that makes the shopping process for the 40M Americans who relocate from a stressful, time consuming and fragmented experience into a interactive process that takes only a few minutes.Read More >
2019 vc speakers
B I O T R A C K
Dispelling Venture Myths at the Intersection of Tech and Bio
Alice joined Upfront in 2018, with a focus on biology and deep tech. Prior to joining Upfront, Alice spent two years at the Boston Consulting Group in San Francisco, where she advised enterprise technology and biopharma clients. Alice also supported business development and operations at the Rare Genomics Institute, a nonprofit connecting families in the rare disease space. Alice received her PhD in biomedical engineering from a joint program between the Georgia Institute of Technology, Emory University, and Peking University.
A Venture Capitalist View of the Future of Biotechnology
Mira Chaurushiya, Ph.D. joined 5AM Ventures in 2015 as an Associate and was promoted to Principal in 2018. Dr. Chaurushiya joined from Genentech where she was a Postdoctoral Fellow in the Department of Physiological Chemistry studying mouse models of cancer and stem cells. Prior to Genentech, she completed her Ph.D. work at the Salk Institute, where she studied Herpes Simplex Virus infections and epigenetics. Her work has been published in Science and PNAS, among others.
Building a Biotech Company
ARCH Venture Partners
Carol is a Senior Associate with ARCH Venture Partners. Carol focuses on identifying and evaluating new life science technologies and also provides operating assistance to early-stage portfolio companies. Carol is a stem cell biologist by training and combines her scientific expertise with experience on the business side of biotech. Prior to ARCH, Carol helped launch Magenta Therapeutics, a biotech company transforming the way bone marrow stem cell transplants are performed.
T E C H T R A C K 1
Long-term opportunities in Industry Specific SaaS
Investment Group of Santa Barbara
Michael will discuss B2B SAAS. Investment Group of Santa Barbara (IGSB) is a private investment company and familyoffice focused on building world-class software businesses. We were founded in 1968 andhave never taken capital from outside investors. Over our 50+ year history we have builtmore than 30 companies as lead investors. IGSB makes direct investments in both privateand public companies emphasizing a concentrated portfolio and significant strategicinvolvement.rformed.
Start Up vs. Scale Up
Jack joined PeakSpan Capital in 2016. Prior to joining PeakSpan, Jack was a team member in the Technology, Media and Telecommunications Investment Banking Group at Macquarie Capital where he evaluated principal investing opportunities, provided M&A advisory services and worked on a number of capital markets transactions with growth-stage technology businesses.
The Global Tech Landscape & Current Trends in AI and Robotics
As an entrepreneur-turned-VC, Jay has over 10 years of startup and venture capital experience and a proven track record of success. Jay currently manages T Fund, a global cross-border venture fund, and invests in tech companies across all stages. Jay was previously a senior director/partner at Walden Venture Capital, one of the pioneer venture capital firms in Silicon Valley.
T E C H T R A C K 2
The Venture World in Tech Today
Prior to joining Greycroft, Brentt led business development at Operator Inc., a venture stage company in the conversational commerce space and worked on technology commercialization at Numenta Inc., an artificial intelligence research company. Brentt also worked at Detroit Venture Partners, where he led investment diligence and supported portfolio companies. Brentt started his career in investment banking at Credit Suisse in Los Angeles, focusing on leveraged buyouts and debt financing transactions.
Why You Don’t Need to Move Your Startup to SF
“Suz” is an associate on the Pelion investment team, Suz focuses on building Pelion’s sourcing pipeline, performing due diligence, and working with existing portfolio companies. Suz is passionate about investing in companies that will change the world as we know it today. She is focused in sourcing interesting deals within Vertical SaaS and Frontier Tech, and spends time researching companies within industries she believes are ready for disruption.
Graduating From Seed? How to Nail Your Series A Fundraising Process
Chirag is a partner at Threshold and invests in consumer-facing technology companies. He is on the board of directors of BentoBox and Loftium and is closely involved with Threshold’s investments in Front and LaunchDarkly.
Co-founder of True Ventures
Phil is an early stage venture capitalist and co-founder of True Ventures. He learned the venture trade and met his future True Ventures co-founder during his time at Summit Partners. He held general partner positions for eight years prior to raising and investing a small angel fund called Blacksmith Capital, which became a seminal moment in his career of managing venture fund investments.
Phil believes in risk-taking at the earliest stage and that startup founders benefit most when they are supported fully, both professionally and personally.